Abstract
The measurement of response to bronchodilators by recording the change in forced expiratory volume in 1 second (F.E.V.1·0) can underestimate response unless the correct time for postbronchodilator tests is chosen. In 18 patients given isoprenaline, the time of peak response varied, but a 30-minute testing time gave the closest approximation to peak response. In order to test whether repeated doses would increase the response, inhalations of isoprenaline were given at 30-minute intervals, the F.E.V.1·0 being measured after each dose. There was a further response after successive doses until a plateau was reached, usually after the third dose. The maximum response obtained was often considerably greater than the response after the first administration of isoprenaline, the average increase in F.E.V.1·0 being 600 ml. after the first dose and 840 ml. after repeated doses. A similar response was obtained in four patients using orciprenaline spray administered with a metered aerosol, the dose being repeated at hourly intervals. Four patients were given repeated inhalations of isoprenaline until the response reached a plateau, and then 250 mg. of aminophylline was injected intravenously. None of these patients showed any further improvement with aminophylline. The significance of these findings is discussed.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALTOUNYAN R. E. VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN. Thorax. 1964 Sep;19:406–415. doi: 10.1136/thx.19.5.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CHAMBERLAIN D. A., MUIR D. C., KENNEDY K. P. Atropine methonitrate and isoprenaline in bronchial asthma. Lancet. 1962 Nov 17;2(7264):1019–1021. doi: 10.1016/s0140-6736(62)92704-6. [DOI] [PubMed] [Google Scholar]
- EDWARDS G. ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS. Br Med J. 1964 Apr 18;1(5389):1015–1017. doi: 10.1136/bmj.1.5389.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EL-SHABOURY A. H. CONTROLLED STUDY OF A NEW INHALANT IN ASTHMA AND BRONCHITIS. Br Med J. 1964 Oct 24;2(5416):1037–1040. doi: 10.1136/bmj.2.5416.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FEINMANN L., NEWELL D. J. ISOPRENALINE IN THE TREATMENT OF CHRONIC BRONCHITIS; A CONTROLLED TRIAL OF DIFFERENT METHODS OF ADMINISTRATION. Br J Dis Chest. 1963 Jul;57:140–146. doi: 10.1016/s0366-0850(63)80059-9. [DOI] [PubMed] [Google Scholar]
- HUME K. M., GANDEVIA B. Forced expiratory volume before and after isoprenaline. Thorax. 1957 Sep;12(3):276–278. doi: 10.1136/thx.12.3.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HUME K. M., RHYS JONES E. The response to bronchodilators in intrinsic asthma. Q J Med. 1961 Apr;30:189–199. [PubMed] [Google Scholar]
- KAY A. W. Effect of large doses of histamine on gastric secretion of HCI; an augmented histamine test. Br Med J. 1953 Jul 11;2(4827):77–80. doi: 10.1136/bmj.2.4827.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KENNEDY M. C., THURSBY-PELHAM D. C. SOME ADRENERGIC DRUGS AND ATROPINE METHONITRATE GIVEN BY INHALATION FOR ASTHMA: A COMPARATIVE STUDY. Br Med J. 1964 Apr 18;1(5389):1018–1021. doi: 10.1136/bmj.1.5389.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PAIN M. C., READ J. PATTERNS OF RESPONSE TO BRONCHODILATOR IN YOUNG PATIENTS WITH ASTHMA. Australas Ann Med. 1963 Aug;12:216–220. doi: 10.1111/imj.1963.12.3.216. [DOI] [PubMed] [Google Scholar]
- SAUNDERS K. B. MISUSE OF INHALED BRONCHODILATOR AGENTS. Br Med J. 1965 Apr 17;1(5441):1037–1038. doi: 10.1136/bmj.1.5441.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WOOLCOCK A. J., PAIN M. C. ASSESSMENT OF ORCIPRENALINE ("ALUPENT"), A LONG-ACTING BRONCHODILATOR. Med J Aust. 1964 Jul 18;2:89–90. [PubMed] [Google Scholar]
